BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 11959214)

  • 1. Histopathological findings in heart transplant patients under tacrolimus-mycophenolate mofetil versus cyclosporine microemulsion-azathioprine.
    Sgrosso JL; Ferrer J; Araujo G; Romeo L; Parisi C; Vázquez MC
    Transplant Proc; 2002 Feb; 34(1):115-6. PubMed ID: 11959214
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients.
    Teebken OE; Strüber M; Harringer W; Pichlmaier MA; Haverich A
    Transplant Proc; 2002 Jun; 34(4):1265-8. PubMed ID: 12072335
    [No Abstract]   [Full Text] [Related]  

  • 3. Improved survival after lung transplantation in patients treated with tacrolimus/mycophenolate mofetil as compared with cyclosporine/azathioprine.
    Izbicki G; Shitrit D; Aravot D; Sulkes J; Saute M; Sahar G; Kramer MR
    Transplant Proc; 2002 Dec; 34(8):3258-9. PubMed ID: 12493439
    [No Abstract]   [Full Text] [Related]  

  • 4. Mycophenolate mofetil reduces anti-HLA antibody production and cellular rejection in heart transplant recipients.
    Lietz K; John R; Schuster M; Ankersmit J; Burke E; Suciu-Foca N; Edwards N; Mancini D; Itescu S
    Transplant Proc; 2002 Aug; 34(5):1828-9. PubMed ID: 12176593
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidence of humoral rejection in heart transplant recipients treated with tacrolimus or cyclosporine A.
    Behr TM; Richter K; Fischer P; Spes CH; Meiser B; Reichart B; Pongratz D; Feucht H; Theisen K; Angermann CE
    Transplant Proc; 1998 Aug; 30(5):1920-1. PubMed ID: 9723333
    [No Abstract]   [Full Text] [Related]  

  • 6. Tolerability of mycophenolate mofetil in organ transplant recipients.
    Schweizer RT; Meisterling LD
    Transplant Proc; 2001 May; 33(3):2309. PubMed ID: 11377540
    [No Abstract]   [Full Text] [Related]  

  • 7. Low doses of mycophenolate mofetil with low doses of tacrolimus prevent acute rejection and long-term function loss after lung transplantation.
    Gerbase MW; Spiliopoulos A; Fathi M; Nicod LP
    Transplant Proc; 2001 May; 33(3):2146-7. PubMed ID: 11377481
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
    Johnson C; Ahsan N; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; van Veldhuisen P; Salm K; Tolzman D; Fitzsimmons WE
    Transplantation; 2000 Mar; 69(5):834-41. PubMed ID: 10755536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
    Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus and azathioprine versus cyclosporine and mycophenolate mofetil after lung transplantation: a retrospective cohort study.
    Celik MR; Lederer DJ; Wilt J; Eser D; Bacchetta M; D'Ovidio F; Sonett JR; Arcasoy SM
    J Heart Lung Transplant; 2009 Jul; 28(7):697-703. PubMed ID: 19560698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased rejection episodes in African-American renal transplant recipients receiving mycophenolate mofetil/tacrolimus therapy.
    Weber M; Deng S; Arenas J; Aradhye S; Grossman R; Shaw L; Naji A; Barker C; Brayman KL
    Transplant Proc; 1997 Dec; 29(8):3669-70. PubMed ID: 9414883
    [No Abstract]   [Full Text] [Related]  

  • 12. Triple therapy with mycophenolate mofetil versus azathioprine.
    Muñiz ML; Amenabar J; Gómez-Ullate P; Urbizu J; Lampreabe I
    Transplant Proc; 1999; 31(1-2):1144-6. PubMed ID: 10083512
    [No Abstract]   [Full Text] [Related]  

  • 13. Tacrolimus-based immunosuppressive protocols in lung transplantation.
    Reichenspurner H; Kur F; Treede H; Meiser BM; Welz A; Vogelmeier C; Schwaiblmeier M; Müller C; Fürst H; Briegel J; Reichart B
    Transplant Proc; 1999; 31(1-2):171-2. PubMed ID: 10083062
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-T-cell-antibody prophylaxis in children: success with a novel combination strategy of mycophenolate mofetil and antithymocyte serum.
    Boucek MM; Pietra B; Sondheimer H; Luna M; Shaffer E; Hall P; Campbell D
    Transplant Proc; 1997 Dec; 29(8A):16S-20S. PubMed ID: 9414669
    [No Abstract]   [Full Text] [Related]  

  • 15. New immunosuppressive agents in clinical use: mycophenolate mofetil and tacrolimus.
    Hunt SA
    Cardiol Rev; 2000; 8(3):180-4. PubMed ID: 11174892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate mofetil versus azathioprine in simultaneous pancreas-kidney transplant recipients on cyclosporine.
    Fabrega AJ; Corwin CL; Hunsicker L
    Transplant Proc; 1998 Jun; 30(4):1562-3. PubMed ID: 9636634
    [No Abstract]   [Full Text] [Related]  

  • 17. Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients.
    Esmeraldo RM; Donadi MO; Oliveira ML; Ponte CN; Pinheiro PM
    Transplant Proc; 1999 Nov; 31(7):3007-8. PubMed ID: 10578367
    [No Abstract]   [Full Text] [Related]  

  • 18. Benefits of mycophenolate mofetil in cardiac transplant recipients with cyclosporine-induced nephropathy.
    Sánchez V; Delgado JF; Blasco T; Dalmau R; Morales JM; Escribano P; Tello R; Hernández J; Velázquez T; Sotelo T; Gómez-Sánchez MA; Sáenz de la Calzada C
    Transplant Proc; 1999 Sep; 31(6):2515-6. PubMed ID: 10500695
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
    Gonwa T; Johnson C; Ahsan N; Alfrey EJ; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; VanVeldhuisen P; Leonhardt M; Fitzsimmons WE
    Transplantation; 2003 Jun; 75(12):2048-53. PubMed ID: 12829910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart transplantation under cyclosporine or tacrolimus combined with mycophenolate mofetil or everolimus.
    Wang SS; Chou NK; Chi NH; Wu IH; Chen YS; Yu HY; Huang SC; Wang CH; Ko WJ; Tsao CI; Sun CD
    Transplant Proc; 2008 Oct; 40(8):2607-8. PubMed ID: 18929814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.